Human Dual-Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A in complex with a consensus sub…
HeteromerQ5IJ48 ; 136-480
100.0 1×D15; 1×CL; Crystal structure of DYRK1A in complex with AZ191 homo-4-mer 134-480
100.0 4×QS0; 32×EDO; 2×SO4; Crystal structure of human DYRK1A in complex with compound 14 monomer 134-483
100.0 6×SO4; 1×9OF; 1×PGE; Human DYRK1A in complex with Leucettine L41 monomer 132-481
100 1×3RA; Crystal Structure of DYRK1A with small molecule inhibitor monomer 134-482
100.0 3×SO4; 7×EDO; 1×KQK; Crystal structure of DYRK1A complexed with FC162 inhibitor monomer 134-482
100 2×SO4; 2×PG4; 1×DMS; 1×JHW; Crystal structure of DYRK1A with harmine-derivatized AnnH-75 inhibitor monomer 134-482
100 1×PG4; 1×4H5; DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133. monomer 131-479
100.0 1×Q8J; Crystal structure of DYRK1A in complex with 10-Chloro-substituted 11H-indolo[3,2-c]quinolone-6-carb… monomer 134-481
100.0 6×SO4; 12×EDO; 1×4E2; 1×IOD; Crystal structure of DYRK1AA in complex with 10-Bromo-substituted 11H-indolo[3,2-c]quinolone-6-carb… monomer 134-481
100.0 5×SO4; 9×EDO; 1×4E3; DYRK1A in complex with hydroxy benzothiazole fragment monomer 134-481
100.0 1×QIV; DYRK1a in Complex with a Bromo-Triazolo-Pyridine monomer 135-482
100 2×IWU; 1×PG4; 1×PEG; 2×PGE; 1×GOL; 1×EPE; 1×1PE; 5×SO4; 3×CL; Crystal structure of DYRK1A in complex with RD0392 monomer 134-481
100.0 1×4VZ; 3×GOL; human DYRK1A/harmine complex monomer 134-481
100.0 1×HRM; human DYRK1A/inhibitor complex monomer 134-481
100.0 1×EHB; Crystal structure of DYRK1A in complex with RD0448 monomer 134-481
100.0 1×4WD; Human DYRK1A in complex with LDN-211898 monomer 134-481
100.0 1×AWR; 2×PO4; Crystal Structure of DYRK1A with small molecule inhibitor monomer 135-481
100.0 6×SO4; 1×KQW; Crystal Structure of DYRK1A with small molecule inhibitor monomer 135-481
100.0 6×SO4; 1×KRQ; 1×EDO; Crystal Structure of DYRK1A with small molecule inhibitor monomer 134-480
100.0 1×KRK; 6×EDO; 1×DMS; 4×SO4; Crystal structure of the human DYRK1A kinase domain bound to abemaciclib monomer 134-480
100.0 2×FLC; 1×6ZV; 8×EDO; 1×PEG; 1×LI; Crystal structure of human DYRK1A in complex with compound 32 monomer 134-480
100.0 1×9OL; DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENT monomer 134-480
100.0 1×AJG; DYRK1A in complex with XMD7-117 monomer 134-480
100.0 1×B5T; DYRK1a in Complex with 2-Cyclopentyl-7-iodo-1H-indole-3-carbonitrile monomer 135-481
100 1×YOX; 2×1PE; 1×PG4; 1×EPE; 2×PEG; 3×GOL; 2×EDO; 8×SO4; DYRK1A in complex with XMD14-124 monomer 134-480
100.0 1×B6Z; Crystal structure of DYRK1A in complex with rutin monomer 134-480
100.0 1×RUT; DYRK1A in complex with JWC-055 monomer 134-480
100.0 1×B6N; DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT monomer 134-480
100.0 1×Y3L; Crystal Structure of DYRK1A with small molecule inhibitor monomer 135-481
100 1×SO4; 1×PG4; 1×KR8; Crystal structure of human DYRK1A in complex with ARN25068 monomer 135-481
100.0 1×39I; Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A monomer 135-481
100 1×D15; 1×CL; 3×P6G; 1×SO4; DYRK1A in complex with XMD15-27-2 monomer 134-480
100.0 1×B6H; DYRK1A in complex with HG-8-60-1 monomer 134-480
100.0 1×B5Z; Crystal Structure of DYRK1A with small molecule inhibitor monomer 134-480
100.0 1×CL; 1×KQE; DYRK1A in complex with XMD8-49 monomer 134-480
100.0 1×B6B; DYRK1A in complex with XMD8-62e monomer 134-480
100.0 1×B7B; Crystal structure of DYRK1A in complex with 10-Iodo-substituted 11H-indolo[3,2-c]quinoline-6-carbox… monomer 135-481
100 2×PG4; 2×SO4; 1×4E1; Human DYRK1A in complex with PKC412 monomer 134-480
100.0 1×2K2; DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT monomer 134-480
100.0 1×5PW; DYRK1A in complex with methoxy benzothiazole fragment monomer 134-480
100.0 1×7QQ; DYRK1A in complex with JWD-065 monomer 134-480
100.0 1×B6Q; DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT monomer 134-480
100.0 1×ZC3; Crystal structure of DYRK1A complexed with KuFal319 (compound 11) monomer 135-481
100 3×PG4; 3×SO4; 1×MLW; DYRK1A in complex with XMD7-112 monomer 134-480
100.0 1×B7W; DYRK1A bound to a harmine derivative monomer 135-481
100 1×QKG; 3×PG4; DYRK1A with PST001 monomer 134-480
100.0 1×OPW; Crystal Structure of DYRK1A with small molecule inhibitor monomer 135-480
100.0 3×SO4; 1×KQZ; 3×EDO; Structure of DYRK1A in complex with AMPNP monomer 136-481
100.0 1×ANP; Crystal structure of DYRK1A in complex with gossypin monomer 135-480
100 1×R7O; 1×ACT; Structure of DYRK1A in complex with compound 8 monomer 136-481
100.0 1×QZ2; The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor monomer 135-480
100 1×2C3; 2×1PE; 2×SO4; Structure of DYRK1A in complex with complex 10 monomer 136-481
100.0 1×MFR; A natural inhibitor of DYRK1A for treatment of diabetes mellitus monomer 135-480
100.0 1×EKU; Structure of DYRK1A in complex with compound 3 monomer 136-481
100.0 1×QYH; Crystal structure of DYRK1A in complex with CX-4945 monomer 135-480
100 1×3NG; 5×SO4; 2×PG4; 1×PEG; 3×EDO; The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor monomer 136-481
100.0 1×2C4; 2×1PE; 2×SO4; DYRK1A complex with DYR530 monomer 136-480
100.0 1×XIR; 1×PG4; 2×GOL; Structure of DYRK1A in complex with compound 16 monomer 148-481
100.0 2×CL; 1×QYW; Structure of DYRK1A in complex with compound 4 monomer 148-481
100.0 1×6SD; Structure of DYRK1A in complex with compound 54 monomer 148-481
100.0 1×RK2; 1×DMS; Structure of DYRK1A in complex with compound 5 monomer 148-481
100.0 1×QYK; Structure of DYRK1A in complex with compound 50 monomer 148-481
100.0 1×RK5; 1×CL; Structure of DYRK1A in complex with compound 25 monomer 148-481
100.0 1×RJ8; 2×CL; Structure of DYRK1A in complex with compound 3 monomer 148-481
100.0 1×RJ5; 2×CL; Structure of DYRK1A in complex with compound 53 monomer 148-481
100.0 1×RHH; 1×PO4; 1×DMS; Structure of DYRK1A in complex with compound 38 monomer 148-481
100.0 1×RKK; 1×CL; tructure of DYRK1A in complex with compound 24 monomer 148-481
100.0 1×QZW; 1×CL; Structure of DYRK1A in complex with compound 28 monomer 148-481
100.0 1×RJ2; 2×CL; Structure of DYRK1A in complex with compound 7 monomer 148-481
100.0 1×QYZ; Structure of DYRK1A in complex with compound 51 monomer 148-481
100.0 1×RKZ; 1×CL; Structure of DYRK1A in complex with compound 34 monomer 148-481
100.0 1×R05; 1×CL; Structure of DYRK1A in complex with compound 58 monomer 148-481
100.0 1×RK8; Structure of DYRK1A in complex with compound 56 monomer 148-481
100.0 1×RJZ; Structure of DYRK1A in complex with compound 5 monomer 149-481
100.0 1×RHZ; 2×CL; Structure of DYRK1A in complex with compound 10 monomer 149-481
100.0 1×RHW; 2×CL; Structure of DYRK1A in complex with compound 46 monomer 149-481
100.0 1×RKQ; 2×CL; Structure of DYRK1A in complex with compound 16 monomer 149-481
100.0 1×RHT; 2×CL; Structure of DYRK1A in complex with compound 2 monomer 149-481
100.0 1×QYE; Structure of DYRK1A in complex with compound 1 monomer 148-479
100.0 1×QY8; 1×DMS; Structure of DYRK1A in complex with compound 6 monomer 148-479
100.0 1×QYB; 2×PO4; Structure of DYRK1A in complex with compound 33 monomer 148-479
100.0 1×RKH; 1×GOL; Structure of DYRK1A in complex with compound 32 monomer 148-479
100.0 1×RKW;